EGFR and urinary bladder carcinoma: “L17 Signaling Pathway (RNO04657)”, “selenocompound metabolism (RNO00450)”, “non-small cell lung cancer (RNO05223)”, “melanoma (RNO05218)”, “bladder cancer (RNO05219)”, “EGFR tyrosine kinase inhibitor resistance (RNO01521)”,”adipocytokine signaling pathway (RNO04920)”, “sphingolipid signaling pathway (RNO04071)”, “MAPK signaling pathway (RNO04010)”, “estrogen signaling pathway (RNO04915)”, and “RAS signaling pathway (RNO04014)” were upregulated while “steroid hormone biosynthesis (RNO00140)”, and “oocyte meiosis (RNO04114)” were downregulated at 1 day post-injury.